 |
Atropine
|
|
|
| General Principles: |
Indications |
Precautions |
|
|
|
Second drug (after epinephrine or vasopressin)
for asystole or bradycardic pulseless electrical activity (Class llb). |
Use with caution in presence of myocardial ischemia
and hypoxia. Increases myocardial oxygen demand.
|
|
| |
First drug for symptomatic sinus bradycardia (Class
I). |
Avoid in hypothermic bradycardia.
|
|
| |
|
May be beneficial in presence of AV block at the nodal level (Class Ia)
or ventricular asystole.
Will not be effective for infranodal (type II) AV block and new third-degree
block with wide QRS complexes. (In these patients may cause paradoxical
slowing. Be prepared to pace or give catecholamines.)
|
|
|
|
|
|
Dosing for:


|
Cardiac Arrest
1 mglVpush.
o Repeat every 3 to 5 minutes (if asystole persists) to a maximum dose
of 0.03 to 0.04 mg/kg.
Tracheal Administration
2 to 3 mg diluted in 10 mL normal saline.
Can be given via tracheal tube
|
|
|
|

Symptomatic Bradycardia
(Note: Not effective in third degree (Complete) heart block. )
|
Bradycardia
0.5 to 1.0 mg IV every 3 to 5 minutes as needed, not to exceed total dose
of 0.04 mg/kg.
Use shorter dosing interval (3 minutes) and higher doses (0.04 mg/kg) in
severe clinical conditions.
Tracheal Administration
2 to 3 mg diluted in 10 mL normal saline.
Can be given via tracheal tube
|
 |
|